QR koda

Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamases.

YTR 830, a new beta-lactamase inhibitor, combined with amoxicillin or carbenicillin, showed a synergistic effect similar to that observed with clavulanic acid, and generally better than that with sulbactam, against strains harboring chromosome-encoded penicillinases and broad-spectrum beta-lactamase...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Antimicrob Agents Chemother
Principais autores: Gutmann, L, Kitzis, M D, Yamabe, S, Acar, J F
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology (ASM) 1986
Teme:
Online dostop:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284193/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3015011/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.29.5.955
Oznake: Označite
Brez oznak, prvi označite!